http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-500202015-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c9e04c7aad66eb7457f7b4b6895112b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc1b8782196f9a58157498c78eeaa662 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2015-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b97c2a9d04c690e98e77090f6f3f2a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7b57bbee58ea14db9edba083023c9bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a04dc4e0952544979b50b41830825589 |
| publicationDate | 2016-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SK-500202015-A3 |
| titleOfInvention | Activated blood plasma |
| abstract | Activated blood plasma is recovered from the blood of the harvested organism, which has been treated with at least two non-damaging stressors, preconditioning and postconditioning, preferably ischemic preconditioning and postconditioning, with an interval of 48 hours between applications, activating in blood plasma 5 hours after the second stress at least one proteinaceous defensive substance. Such blood plasma, upon administration to the recipient, is able to prevent or limit the consequences of acute ischemic and reperfusion injury to the organism and its parts. |
| priorityDate | 2015-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.